Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | CTSL | P07711 | 5/20 | 0.39 |
| ▸ | MMP1 | P03956 | 1/20 | 0.39 |
| ▸ | MMP9 | P14780 | 3/20 | 0.39 |
| ▸ | MMP8 | P22894 | 3/20 | 0.39 |
| ▸ | MMP2 | P08253 | 2/20 | 0.39 |
| ▸ | CPA1 | P15085 | 3/20 | 0.38 |
| ▸ | CPA2 | P48052 | 3/20 | 0.38 |
| ▸ | CPA4 | Q9UI42 | 3/20 | 0.38 |
| ▸ | CPB1 | P15086 | 1/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | CTSS | P25774 | 6/20 | 0.38 |
| ▸ | CTSK | P43235 | 3/20 | 0.36 |
| ▸ | CTSB | P07858 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MMP14 | P50281 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3834367 | 1.00 | ALDH1A1 (0.55) | ALDH1A1CTSLMMP1MMP9MMP8 | |
| SCHEMBL1006669 | 0.85 | ALDH1A1 (0.50) | ALDH1A1MMP1MEN1LMNAKMT2A | |
| SCHEMBL1006670 | 0.85 | ALDH1A1 (0.50) | ALDH1A1MMP1MEN1LMNAKMT2A | |
| SCHEMBL14283754 | 0.85 | ALDH1A1 (0.53) | ALDH1A1CTSLCTSSCTSKCTSB | |
| SCHEMBL9114022 | 0.84 | CTSB (0.50) | ALDH1A1CTSSCTSKCTSB | |
| SCHEMBL15539031 | 0.84 | CTSS (0.49) | ALDH1A1CTSLMMP1MMP9MMP8 | |
| SCHEMBL3923432 | 0.82 | CTSB (0.49) | ALDH1A1CTSSCTSKCTSB | |
| SCHEMBL2184616 | 0.82 | MMP2 (0.39) | ALDH1A1CTSLMMP9MMP8MMP2 | |
| SCHEMBL27589724 | 0.82 | MMP9 (0.39) | ALDH1A1CTSLMMP9MMP8MMP2 | |
| SCHEMBL28082201 | 0.82 | MMP2 (0.39) | ALDH1A1CTSLMMP9MMP8MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010034128-A1 | SPY1A AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF CANCER | UNIVERSITY OF WINDSOR (CA) | 2010-04-01 | — | — | WO | disclosed |
| EP-2131866-A2 | DUAL ACTING PRODRUGS | KTB Tumorforschungsgesellschaft mbH (DE) | 2009-12-16 | — | — | EP | disclosed |
| CN-101472899-A | 2-substituted 4-benzylphthalazinone derivatives as histamine H1 and H3 antagonists | GLAXO GROUP LTD (GB) | 2009-07-01 | — | — | CN | disclosed |
| WO-2009040816-A1 | METHODS OF TREATING LYSOSOMAL STORAGE DISORDERS | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2009-04-02 | — | — | WO | disclosed |
| WO-2008098789-A2 | DUAL ACTING PRODRUGS | KTB TUMORFORSCHUNGSGESELLSCHAFT MBH (DE) | 2008-08-21 | — | — | WO | disclosed |
| CN-100400523-C | Substituted piperazines, (1,4) diaza * class and 2, 5-diazabicyclo (2.2.1) heptanes as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists | GLAXO GROUP LTD (GB) | 2008-07-09 | — | — | CN | disclosed |
| CN-101070309-A | Substituted piperazines as histamine H1 and/or H3 antagonists or histamine H3 reverse antagonists, (1, 4) diazabi and 2, 5-diazabicyclo (2.2.1) heptanes | GLAXO GROUP LTD (GB) | 2007-11-14 | — | — | CN | disclosed |
| EP-1831352-A2 | CELL LINES FOR PRODUCTION OF REPLICATION-DEFECTIVE ADENOVIRUS | CANJI, Inc. (US) | 2007-09-12 | — | — | EP | disclosed |
| US-7211424-B1 | Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity | INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL (CA) | 2007-05-01 | — | — | US | disclosed |
| WO-2006065827-A9 | CELL LINES FOR PRODUCTION OF REPLICATION-DEFECTIVE ADENOVIRUS | CANJI INC (US) | 2006-08-24 | — | — | WO | disclosed |
| WO-2005118580-A2 | TRICYCLIC COMPOUNDS AS INHIBITORS OF THE HYPOXIC SIGNALING PATHWAY | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH (US) | 2005-12-15 | — | — | WO | disclosed |
| WO-2005115429-A1 | METHODS AND KITS FOR DIAGNOSING AND/OR ASSESSING SEVERITY AND TREATING GAUCHER DISEASE | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2005-12-08 | — | — | WO | disclosed |
| EP-1390497-A2 | HUMAN CDNAS AND PROTEINS AND USES THEREOF | Genset (FR) | 2004-02-25 | — | — | EP | disclosed |
| WO-2002101012-A9 | REGULATION OF TRANSGENE EXPRESSION FOLLOWING AAV TRANSDUCTION | CHILDREN S HOSPITAL RES FOUNDA (US) | 2003-12-18 | — | — | WO | disclosed |
| WO-2002101012-A2 | REGULATION OF TRANSGENE EXPRESSION FOLLOWING AAV TRANSDUCTION | CHILDREN'S HOSPITAL RESEARCH FOUNDATION (US) | 2002-12-19 | — | — | WO | disclosed |
| WO-2002094864-A2 | HUMAN CDNAS AND PROTEINS AND USES THEREOF | GENSET S.A. (FR) | 2002-11-28 | — | — | WO | disclosed |
| WO-2002020545-A1 | ANTISENSE MODULATION OF A20 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2002-03-14 | — | — | WO | disclosed |
| EP-1129181-A2 | MAMMALIAN SUBTILISIN/KEXIN ISOZYME SKI-1: A PROPROTEIN CONVERTASE WITH A UNIQUE CLEAVAGE SPECIFICITY | INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL (CA) | 2001-09-05 | — | — | EP | disclosed |
| WO-2000026348-A2 | MAMMALIAN SUBTILISIN/KEXIN ISOZYME SKI-1: A PROPROTEIN CONVERTASE WITH A UNIQUE CLEAVAGE SPECIFICITY | INSTITUT DE RECHERCHES CLINIQUES DE MONTREAL (CA) | 2000-05-11 | — | — | WO | disclosed |
| EP-0800528-A1 | PEPTIDE AND PEPTIDE ANALOG PROTEASE INHIBITORS | Sibia Neurosciences, Inc. (US) | 1997-10-15 | — | — | EP | disclosed |